CG Oncology

BiotechnologySeries FIrvine, UScgoncology.com

Latest round

Series F

Last raised

Aug 2023

Total raised

$318M

Investors

18

About CG Oncology

, operates as a clinical-stage biopharmaceutical company that develops immunotherapeutic drugs for oncolytic studies for the treatment of patients with advanced cancer. In January 2024, CG Oncology, Inc." CG Oncology, Inc. has granted the underwriters a 30-day option to purchase up to an additional 3 million shares of common stock as part of the listing., Ltd.4% minority stake in the company, respectively. The company provides a wide range of clinical biopharmaceutical products, such as cretostimogene grenadenorepvec, an investigational-engineered oncolytic immunotherapy. This therapy is in clinical trials for treating BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) both as a monotherapy and in combination with other treatments.

Who invested in CG Oncology

18 investors across 6 rounds

See all investors in CG Oncology

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series F

    Aug 2, 2023

    Amount

    $105M

    Investors

    Locked

  2. Series E

    Sep 30, 2022

    Amount

    $120M

    Investors

    Locked

  3. Series D

    Dec 10, 2020

    Amount

    $47M

    Investors

    Locked

  4. Series C

    Mar 18, 2019

    Amount

    $22M

    Investors

    Locked

  5. Series B

    Aug 5, 2015

    Amount

    $10M

    Investors

    Locked

  6. Series A

    Jul 30, 2014

    Amount

    $14M

    Investors

    Locked

Questions about CG Oncology

Who invested in CG Oncology?

CG Oncology has 18 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has CG Oncology raised?

CG Oncology has raised 6 venture rounds. Sign up free to see how much each round raised and the total.

When did CG Oncology last raise money?

CG Oncology's most recent round on record is a Series F, in Aug 2023.

What does CG Oncology do?

, operates as a clinical-stage biopharmaceutical company that develops immunotherapeutic drugs for oncolytic studies for the treatment of patients with advanced cancer.

Where is CG Oncology headquartered?

CG Oncology is headquartered in Irvine, US.

Which VCs invest in companies like CG Oncology?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CG Oncology's stage. Their profiles are linked below.

Raising like CG Oncology? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.